More specifically, NR3C1 baseline promoter methylation in peripheral blood predicted treatment outcome in PTSD, and in the same study, promoter methylation of FKBP5 decreased in association with symptom improvement [22]. The gene discussed is FKBP5; the disease is post-traumatic stress disorder.